Your browser doesn't support javascript.
loading
Comparison of In Vivo and Ex Vivo MRI for the Detection of Structural Abnormalities in a Mouse Model of Tauopathy.
Holmes, Holly E; Powell, Nick M; Ma, Da; Ismail, Ozama; Harrison, Ian F; Wells, Jack A; Colgan, Niall; O'Callaghan, James M; Johnson, Ross A; Murray, Tracey K; Ahmed, Zeshan; Heggenes, Morten; Fisher, Alice; Cardoso, M Jorge; Modat, Marc; O'Neill, Michael J; Collins, Emily C; Fisher, Elizabeth M C; Ourselin, Sébastien; Lythgoe, Mark F.
Afiliação
  • Holmes HE; Division of Medicine, UCL Centre for Advanced Biomedical Imaging, University College LondonLondon, UK.
  • Powell NM; Division of Medicine, UCL Centre for Advanced Biomedical Imaging, University College LondonLondon, UK.
  • Ma D; Centre for Medical Image Computing, University College LondonLondon, UK.
  • Ismail O; Division of Medicine, UCL Centre for Advanced Biomedical Imaging, University College LondonLondon, UK.
  • Harrison IF; Centre for Medical Image Computing, University College LondonLondon, UK.
  • Wells JA; Division of Medicine, UCL Centre for Advanced Biomedical Imaging, University College LondonLondon, UK.
  • Colgan N; Division of Medicine, UCL Centre for Advanced Biomedical Imaging, University College LondonLondon, UK.
  • O'Callaghan JM; Division of Medicine, UCL Centre for Advanced Biomedical Imaging, University College LondonLondon, UK.
  • Johnson RA; Division of Medicine, UCL Centre for Advanced Biomedical Imaging, University College LondonLondon, UK.
  • Murray TK; Division of Medicine, UCL Centre for Advanced Biomedical Imaging, University College LondonLondon, UK.
  • Ahmed Z; Tailored Therapeutics, Eli Lilly and Company, Lilly Corporate CenterIndianapolis, IN, USA.
  • Heggenes M; Molecular Pathology, Eli Lilly & Co. LtdWindlesham, UK.
  • Fisher A; Molecular Pathology, Eli Lilly & Co. LtdWindlesham, UK.
  • Cardoso MJ; Molecular Pathology, Eli Lilly & Co. LtdWindlesham, UK.
  • Modat M; Molecular Pathology, Eli Lilly & Co. LtdWindlesham, UK.
  • O'Neill MJ; Centre for Medical Image Computing, University College LondonLondon, UK.
  • Collins EC; Centre for Medical Image Computing, University College LondonLondon, UK.
  • Fisher EM; Molecular Pathology, Eli Lilly & Co. LtdWindlesham, UK.
  • Ourselin S; Tailored Therapeutics, Eli Lilly and Company, Lilly Corporate CenterIndianapolis, IN, USA.
  • Lythgoe MF; Department of Neurodegenerative Disease, Institute of Neurology, University College LondonLondon, UK.
Front Neuroinform ; 11: 20, 2017.
Article em En | MEDLINE | ID: mdl-28408879
With increasingly large numbers of mouse models of human disease dedicated to MRI studies, compromises between in vivo and ex vivo MRI must be fully understood in order to inform the choice of imaging methodology. We investigate the application of high resolution in vivo and ex vivo MRI, in combination with tensor-based morphometry (TBM), to uncover morphological differences in the rTg4510 mouse model of tauopathy. The rTg4510 mouse also offers a novel paradigm by which the overexpression of mutant tau can be regulated by the administration of doxycycline, providing us with a platform on which to investigate more subtle alterations in morphology with morphometry. Both in vivo and ex vivo MRI allowed the detection of widespread bilateral patterns of atrophy in the rTg4510 mouse brain relative to wild-type controls. Regions of volume loss aligned with neuronal loss and pathological tau accumulation demonstrated by immunohistochemistry. When we sought to investigate more subtle structural alterations in the rTg4510 mice relative to a subset of doxycycline-treated rTg4510 mice, ex vivo imaging enabled the detection of more regions of morphological brain changes. The disadvantages of ex vivo MRI may however mitigate this increase in sensitivity: we observed a 10% global shrinkage in brain volume of the post-mortem tissues due to formalin fixation, which was most notable in the cerebellum and olfactory bulbs. However, many central brain regions were not adversely affected by the fixation protocol, perhaps due to our "in-skull" preparation. The disparity between our TBM findings from in vivo and ex vivo MRI underlines the importance of appropriate study design, given the trade-off between these two imaging approaches. We support the utility of in vivo MRI for morphological phenotyping of mouse models of disease; however, for subtler phenotypes, ex vivo offers enhanced sensitivity to discrete morphological changes.
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Front Neuroinform Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Front Neuroinform Ano de publicação: 2017 Tipo de documento: Article